National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 54225-54226 [2022-19049]

Download as PDF Federal Register / Vol. 87, No. 170 / Friday, September 2, 2022 / Notices from approximately 9 a.m. to 5 p.m. ET (times are tentative and subject to change) each day. The confirmed times and agenda items for the meeting will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 2022-10-04/ when this information becomes available. FOR FURTHER INFORMATION CONTACT: lotter on DSK11XQN23PROD with NOTICES1 James Berger, Designated Federal Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Mary E. Switzer Building, 330 C Street SW, Suite L600, Washington, DC 20024. Email: tickbornedisease@ hhs.gov. Phone: 202–795–7608. Dated: August 23, 2022. James J. Berger, Designated Federal Officer, Tick-Borne Disease Working Group, Office of Infectious Disease and HIV/AIDS Policy. [FR Doc. 2022–18972 Filed 9–1–22; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the SUPPLEMENTARY INFORMATION: A link to following meeting. view the webcast can be found on the The meeting will be closed to the meeting website at https://www.hhs.gov/ public in accordance with the ash/advisory-committees/ provisions set forth in sections tickbornedisease/meetings/2022-10-04/ 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., index.html when it becomes available. as amended. The grant applications and The public will have an opportunity to present their views to the TBDWG orally the discussions could disclose confidential trade secrets or commercial during the meeting’s public comment property such as patentable material, session or by submitting a written and personal information concerning public comment. Comments should be individuals associated with the grant pertinent to the meeting discussion. applications, the disclosure of which Persons who wish to provide verbal or would constitute a clearly unwarranted written public comment should review invasion of personal privacy. instructions at https://www.hhs.gov/ ash/advisory-committees/ Name of Committee: Microbiology, tickbornedisease/meetings/2022-10-04/ Infectious Diseases and AIDS Initial Review Group; Microbiology and Infectious Diseases index.html and respond by midnight B Research Study Section Microbiology and September 26, 2022 ET. Verbal Infectious Diseases B Research Study comments will be limited to three Section. minutes each to accommodate as many Date: October 26–27, 2022. speakers as possible during the 30Time: 11:00 a.m. to 5:30 p.m. minute session. Written public Agenda: To review and evaluate grant comments will be accessible to the public on the TBDWG web page prior to applications. Place: National Institute of Allergy and the meeting. Infectious Diseases, National Institutes of Background and Authority: The Tick- Health, 5601 Fishers Lane, Room 3F58, Borne Disease Working Group was Rockville, MD 20892 (Virtual Meeting). established on August 10, 2017, in Contact Person: Mario Cerritelli, Ph.D., Scientific Review Officer, National Institute accordance with Section 2062 of the 21st Century Cures Act, and the Federal of Allergy and Infectious Diseases, National Advisory Committee Act, 5 U.S.C. App., Institutes of Health, 5601 Fishers Lane, Room 3F58, Rockville, MD 20892, 240–669–5199, as amended, to provide expertise and cerritem@mail.nih.gov. review federal efforts related to all tick(Catalogue of Federal Domestic Assistance borne diseases, to help ensure Program Nos. 93.855, Allergy, Immunology, interagency coordination and minimize and Transplantation Research; 93.856, overlap, and to examine research Microbiology and Infectious Diseases priorities. The TBDWG is required to Research, National Institutes of Health, HHS) submit a report to the HHS Secretary Dated: August 30, 2022. and Congress on their findings and any recommendations for the federal Tyeshia M. Roberson-Curtis, response to tick-borne disease every two Program Analyst, Office of Federal Advisory years. Committee Policy. [FR Doc. 2022–19054 Filed 9–1–22; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 16:40 Sep 01, 2022 Jkt 256001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 54225 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed). Date: September 30, 2022. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892 (Virtual Meeting). Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific Review Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892, 301–761–7176, dimitrios.vatakis@ nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed). Date: October 4, 2022. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892 (Virtual Meeting). Contact Person: Dimitrios N. Vatakis, Ph.D., Scientific Review Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G21, Rockville, MD 20892, 301–761–7176, dimitrios.vatakis@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\02SEN1.SGM 02SEN1 54226 Federal Register / Vol. 87, No. 170 / Friday, September 2, 2022 / Notices Dated: August 30, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–19049 Filed 9–1–22; 8:45 am] BILLING CODE 4140–01–P Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice of intent to award supplemental funding. National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. lotter on DSK11XQN23PROD with NOTICES1 Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group Microbiology and Infectious Diseases Research Study Section Microbiology and Infectious Diseases Research Study Section. Date: October 18–19, 2022. Time: 10 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G62, Rockville, MD 20892 (Virtual Meeting). Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G62, Rockville, MD 20892, (240) 669–5081, ecohen@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 30, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P VerDate Sep<11>2014 16:40 Sep 01, 2022 Jkt 256001 Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2022–19051 Filed 9–1–22; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES This is a notice of intent to award supplemental funding to the Suicide Prevention Resource Center (SPRC) recipient funded in FY 2020 under Notice of Funding Opportunity (NOFO) SM–20–11. This is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting an administrative supplement, which is consistent with the scope of the initial award, of up to $1,609,838, for one-year to the SPRC recipient, University of Oklahoma Health Sciences Center. This recipient was funded in FY 2020 under the SPRC Notice of Funding Opportunity (NOFO) SM–20–011 with a project end date of November 30, 2025. This supplement will provide continued support for the HHS Behavioral Health Coordinating Committee’s, Comprehensive Community Suicide Prevention Workgroup in the development of recommendations to increase the community-based suicide prevention infrastructure; provide staff support and technical assistance on a new platform that will be used to train the suicide prevention workforce on approaches to address the needs of individuals at risk for suicide; provide additional suicide prevention technical assistance for states, tribes, territories, and community-based organizations in the implementation of suicide prevention; and conduct an evaluation, in coordination with the National Action Alliance for Suicide Prevention, of 988 call centers to ensure 988 implementation, programmatic and messaging efforts are well informed by the unique needs of populations at high risk or disproportionately impacted by suicide-related behaviors. This is not a formal request for application. Assistance will only be provided to the SPRC Grant recipient, University of Oklahoma Health Sciences Center, based on the receipt of a satisfactory application and associated budget. Funding Opportunity Title: Suicide Prevention Resource Center (SPRC) NOFO SM–20–011. Assistance Listing Number: 93.243. SUMMARY: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Authority: The SPRC grant is authorized under Section 520A and 520C of the Public Health Service Act, as amended. Justification: Eligibility for this supplemental funding is limited to the University of Oklahoma Health Sciences Center which was funded in FY 2020 under the SPRC NOFO SM–20–011. The University of Oklahoma Health Sciences Center since they are currently providing technical assistance on suicide prevention and have specialized expertise conducting needs assessments to understand the attitudes, knowledge, and beliefs regarding suicide of various groups and populations. Contact: Brandon J. Johnson, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, telephone (240) 276–1222; email: brandon.johnson1@samhsa.hhs.gov. Carlos Graham, Reports Clearance Officer. [FR Doc. 2022–18975 Filed 9–1–22; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2022 Notice of Supplemental Funding Opportunity Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice of intent to award supplemental funding. AGENCY: This is a notice of intent to award supplemental funding to the National Center of Excellence for Infant and Early Childhood Mental Health Consultation (COE–IECMH) recipient funded in FY 2019 under Notice of Funding Opportunity (NOFO) SM–19– 010. This is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting an administrative supplement, which is consistent of the initial award, up to $900,000 (for oneyear to Georgetown University). This supplement will provide continued support for the IECMH grantees in their efforts to strengthen their IECMH systems; working with state-level systems and leaders to integrate grantee innovations into ongoing initiatives, policies, and sustainable funding streams, and/or participate in the development of new IECMH efforts; share best practices and advances in infant and early childhood mental health with the early childhood field SUMMARY: E:\FR\FM\02SEN1.SGM 02SEN1

Agencies

[Federal Register Volume 87, Number 170 (Friday, September 2, 2022)]
[Notices]
[Pages 54225-54226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19049]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Research Education Program 
Advancing the Careers of a Diverse Research Workforce (R25 Clinical 
Trial Not Allowed).
    Date: September 30, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G21, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific 
Review Officer, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
3G21, Rockville, MD 20892, 301-761-7176, [email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Biomarker Signatures of TB 
Infection in Young Children With and Without HIV (R01 Clinical Trial 
Not Allowed).
    Date: October 4, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G21, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Dimitrios N. Vatakis, Ph.D., Scientific Review 
Officer, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G21, 
Rockville, MD 20892, 301-761-7176, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 54226]]


    Dated: August 30, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19049 Filed 9-1-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.